Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Selective estrogen receptor modulator].

Hiroaki Ohta1

  • 1Department of Obstetrics and Gynecology, Tokyo Women's Medical University, Tokyo, Japan.

Clinical Calcium
|December 4, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Administration of tirabrutinib suspension in a patient with primary central nervous system lymphoma: A case report.

Oncology letters·2026
Same author

Fractional CO<sub>2</sub> laser therapy for genitourinary syndrome of menopause: symptom-specific trajectories, exposure-outcome associations, and ultrasonographic changes in vulvar soft tissue in a cohort of 826 women.

Frontiers in reproductive health·2026
Same author

Laser-based inertial fusion energy system enabled by optical enhancement cavities and a direct-drive configuration reactor.

Optics express·2025
Same author

Real-world use of non-oral administration of oral anticancer agents via the simple suspension method in Japanese patients with cancer: A nationwide claims-based analysis.

Drug discoveries & therapeutics·2025
Same author

Incidence of Hypothyroidism and Thyroid Function Monitoring After Immune Checkpoint Inhibitor Therapy Completion for Lung Cancer: A Nationwide Analysis of a Japanese Claims Database.

Current oncology (Toronto, Ont.)·2025
Same author

Trends in Kampo Medicine Usage as Supportive Care During Anticancer Drug Treatment in Japanese Patients: A Nationwide Cohort Analysis from Fiscal Years 2015 to 2021.

Current oncology (Toronto, Ont.)·2025

Selective estrogen-receptor modulators (SERMs) offer estrogen

Area of Science:

  • Pharmacology and Endocrinology
  • Oncology
  • Cardiovascular Medicine

Context:

  • The Women's Health Initiative (WHI) trial highlighted risks of Hormone Replacement Therapy (HRT).
  • SERMs emerged as alternatives to HRT, aiming to retain benefits while mitigating risks.
  • Raloxifene, a specific SERM, demonstrated distinct tissue-specific effects compared to HRT.

Purpose:

  • To evaluate the efficacy and safety of Selective Estrogen Receptor Modulators (SERMs).
  • To compare the tissue-specific actions of SERMs, like raloxifene, with traditional HRT.
  • To explore the potential of SERMs in managing conditions like osteoporosis, breast cancer, and coronary heart disease.

Summary:

  • SERMs exhibit tissue-selective estrogenic or anti-estrogenic activity.

Related Experiment Videos

  • Raloxifene acts as an estrogen agonist on bone, reducing osteoporotic fractures.
  • Raloxifene acts as an estrogen antagonist on breast tissue, lowering breast cancer incidence.

    • Impact:

    • SERMs represent a versatile therapeutic class with potential for broader clinical applications.
    • SERMs offer a promising strategy for managing menopausal symptoms and related health risks.
    • Further research is expected to expand the indications and understanding of SERMs in various diseases.